Editor's News Trails
Publisher-associated editorial trails will appear here when an editorial publishing workflow is available.
Publisher profile
biospace.com
Explore recent coverage from this publisher, with reporting context brought together on Scroll News.
Reporting, in context
No article image available
Contract development and manufacturing organizations looking to do business with biopharmas include Lonza, which has more than 30 sites, and Samsung Biologics, which recently announced a planned acquisition of another CDMO.
The trials, which were testing the tyrosine kinase inhibitor masitinib, had previously been paused. AB Science’s decision not to resume them was a matter of prioritization, not safety, the biotech said.
As Congress debates renewing the Act for ALS, it must prepare for the coming era of precision ALS medicine by prioritizing early-stage research to more quickly bring effective treatments to the market.
Follow a story across time
Explore editorial and community perspectives on connected reporting.
Distinct perspectives · No trails available yet
Publisher-associated editorial trails will appear here when an editorial publishing workflow is available.
Public reader-created trails featuring this publisher's coverage are not shown until privacy-safe discovery is available.
Explore the reporting
Browse recurring subjects across this publisher's coverage.
Publisher-specific topics
Topic discovery is not available for this publisher yet.